1. Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria;
2. Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, and
3. Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland;
4. Department of Experimental Oncology and Hematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland;
5. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;
6. Department of Hematology, Centre Hospitalier Universitaire (CHU) de Liège, Liège, Belgium; and
7. Department of Laboratory Medicine, Wilhelminenspital, Vienna, Austria